Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Syndax Pharmaceuticals (SNDX) Debt Ratio (2020 - 2024)

Syndax Pharmaceuticals has reported Debt Ratio over the past 5 years, most recently at 0.47 for Q4 2024.

  • Quarterly results put Debt Ratio at 0.47 for Q4 2024, changed N/A from a year ago — trailing twelve months through Dec 2024 was 0.47 (changed N/A YoY), and the annual figure for FY2024 was 0.47, changed.
  • Debt Ratio for Q4 2024 was 0.47 at Syndax Pharmaceuticals, up from 0.05 in the prior quarter.
  • Over the last five years, Debt Ratio for SNDX hit a ceiling of 0.47 in Q4 2024 and a floor of 0.04 in Q4 2021.
  • Median Debt Ratio over the past 4 years was 0.08 (2021), compared with a mean of 0.12.
  • Peak annual rise in Debt Ratio hit 23.37% in 2021, while the deepest fall reached 61.56% in 2021.
  • Syndax Pharmaceuticals' Debt Ratio stood at 0.07 in 2020, then tumbled by 33.27% to 0.04 in 2021, then increased by 11.32% to 0.05 in 2022, then soared by 853.76% to 0.47 in 2024.
  • The last three reported values for Debt Ratio were 0.47 (Q4 2024), 0.05 (Q2 2022), and 0.05 (Q1 2022) per Business Quant data.